Fingerprint
Dive into the research topics of 'Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma
RELATIVITY-047 Investigators
Research output: Contribution to journal › Article › peer-review
709
Scopus
citations